Tyra Biosciences, Inc. - COMMON STOCK (TYRA)

CUSIP: 90240B106

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
53,803,111
Total 13F shares
35,744,229
Share change
-387,251
Total reported value
$255,572,000
Price per share
$7.15
Number of holders
44
Value change
-$3,322,156
Number of buys
21
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 90240B106?
CUSIP 90240B106 identifies TYRA - Tyra Biosciences, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of TYRA - Tyra Biosciences, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13%
7,236,454
$77,430,000 31 Mar 2022
13F
Boxer Capital, LLC
13F
Company
12%
6,448,359
$68,997,000 31 Mar 2022
13F
Canaan Partners XI LLC
13F
Company
8.2%
4,409,991
$47,187,000 31 Mar 2022
13F
FMR LLC
13F
Company
7.6%
4,090,085
$43,764,000 31 Mar 2022
13F
Nextech Invest Ltd.
13F
Company
4.7%
2,518,582
$26,949,000 31 Mar 2022
13F
Alta Partners NextGen Fund II Management, LLC
3/4/5
10%+ Owner
class O/S missing
4,080,296
$26,844,267 17 Sep 2021
BVF INC/IL
13F
Company
4.6%
2,472,327
$26,454,000 31 Mar 2022
13F
Frazier Life Sciences Management, L.P.
13F
Company
2.5%
1,327,665
$14,206,000 31 Mar 2022
13F
Fairmount Funds Management LLC
13F
Company
2.4%
1,284,990
$13,749,000 31 Mar 2022
13F
JANUS HENDERSON GROUP PLC
13F
Company
1.7%
909,192
$9,718,000 31 Mar 2022
13F
TCG Crossover Management, LLC
13F
Company
1.7%
896,418
$9,592,000 31 Mar 2022
13F
Cormorant Asset Management, LP
13F 3/4/5
Company · Former 10% Owner
1.4%
757,432
$8,105,000 31 Mar 2022
BlackRock Finance, Inc.
13F
Company
1.1%
583,236
$6,242,000 31 Mar 2022
13F
VANGUARD GROUP INC
13F
Company
0.96%
515,637
$5,517,000 31 Mar 2022
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.92%
494,403
$5,290,000 31 Mar 2022
13F
Canaan XI L.P.
3/4/5
10%+ Owner
class O/S missing
473,396
$3,114,472 17 Sep 2021
Woodline Partners LP
13F
Company
0.49%
266,161
$2,848,000 31 Mar 2022
13F
Logos Global Management LP
13F
Company
0.47%
252,726
$2,704,000 31 Mar 2022
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.47%
251,222
$2,688,000 31 Mar 2022
13F
JPMORGAN CHASE & CO
13F
Company
0.42%
228,482
$2,445,000 31 Mar 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.39%
210,549
$2,252,000 31 Mar 2022
13F
STATE STREET CORP
13F
Company
0.38%
203,680
$2,179,000 31 Mar 2022
13F
Ensign Peak Advisors, Inc
13F
Company
0.23%
125,000
$1,338,000 31 Mar 2022
13F
Sio Capital Management, LLC
13F
Company
0.21%
111,033
$1,188,000 31 Mar 2022
13F
NORTHERN TRUST CORP
13F
Company
0.19%
100,104
$1,071,000 31 Mar 2022
13F
D. E. Shaw & Co., Inc.
13F
Company
0.16%
83,438
$893,000 31 Mar 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.15%
80,456
$861,000 31 Mar 2022
13F
CITADEL ADVISORS LLC
13F
Company
0.15%
78,309
$838,000 31 Mar 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.12%
64,126
$686,000 31 Mar 2022
13F
Bank of New York Mellon Corp
13F
Company
0.06%
30,620
$328,000 31 Mar 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.05%
29,300
$314,000 31 Mar 2022
13F
Nuveen Asset Management, LLC
13F
Company
0.03%
18,400
$197,000 31 Mar 2022
13F
RHUMBLINE ADVISERS
13F
Company
0.02%
11,726
$125,000 31 Mar 2022
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.02%
10,517
$113,000 31 Mar 2022
13F
DEUTSCHE BANK AG\
13F
Company
0.01%
6,613
$71,000 31 Mar 2022
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.01%
5,856
$63,000 31 Mar 2022
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.01%
5,064
$54,000 31 Mar 2022
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
2,562
$27,000 31 Mar 2022
13F
BARCLAYS PLC
13F
Company
0%
1,915
$20,000 31 Mar 2022
13F
AMALGAMATED BANK
13F
Company
0%
1,771
$19,000 31 Mar 2022
13F
Amalgamated Financial Corp.
13F
Company
0%
1,771
$19,000 31 Mar 2022
13F
UBS Group AG
13F
Company
0%
1,740
$19,000 31 Mar 2022
13F
MORGAN STANLEY
13F
Company
0%
1,571
$16,000 31 Mar 2022
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
1,243
$13,000 31 Mar 2022
13F
Legal & General Group Plc
13F
Company
0%
1,126
$12,000 31 Mar 2022
13F
Ameritas Investment Partners, Inc.
13F
Company
0%
940
$10,000 31 Mar 2022
13F
ROYAL BANK OF CANADA
13F
Company
0%
725
$8,000 31 Mar 2022
13F
CITIGROUP INC
13F
Company
0%
459
$5,000 31 Mar 2022
13F
Ali D. Fawaz
3/4/5
General Counsel and Secretary
class O/S missing
361,586
16 May 2022

Institutional Holders of Tyra Biosciences, Inc. - COMMON STOCK (TYRA) as of Q2 2022

As of 30 Jun 2022, Tyra Biosciences, Inc. - COMMON STOCK (TYRA) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,744,229 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., BOXER CAPITAL, LLC, Canaan Partners XI LLC, FMR LLC, Nextech Invest AG, BVF INC/IL, Fairmount Funds Management LLC, Frazier Life Sciences Management, L.P., TCG Crossover Management, LLC, and Cormorant Asset Management, LP. This page lists 44 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
46
Q2 2022 holders
44
Holder diff
-2
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 Value $ Q2 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.